Novel MRI deformation-heterogeneity radiomic features are associated with molecular subgroups and overall survival in pediatric medulloblastoma: Preliminary findings from a multi-institutional study

• Published in: Frontiers in oncology 2022-12, Vol.12, p.915143
• Main Authors: Iyer, Sukanya, Ismail, Marwa, Tamrazi, Benita, Salloum, Ralph, de Blank, Peter, Margol, Ashley, Correa, Ramon, Chen, Jonathan, Bera, Kaustav, Statsevych, Volodymyr, Ho, Mai-Lan, Vaidya, Pranjal, Verma, Ruchika, Hawes, Debra, Judkins, Alexander, Fu, Pingfu, Madabhushi, Anant, Tiwari, Pallavi
• Format: Article
• Language: English
• Subjects: deformation; LASSO; medulloblastoma; molecular subgroups; Oncology; survival
• ISSN: 2234-943X; 2234-943X
• DOI: 10.3389/fonc.2022.915143

Medulloblastoma (MB) is a malignant, heterogenous brain tumor. Advances in molecular profiling have led to identifying four molecular subgroups of MB (WNT, SHH, Group 3, Group 4), each with distinct clinical behaviors. We hypothesize that (1) aggressive MB tumors, growing heterogeneously, induce pronounced local structural deformations in the surrounding parenchyma, and (b) these local deformations as captured on Gadolinium (Gd)-enhanced-T1w MRI are independently associated with molecular subgroups, as well as overall survival in MB patients. In this work, a total of 88 MB studies from 2 institutions were analyzed. Following tumor delineation, Gd-T scan for every patient was registered to a normal age-specific T -MRI template via deformable registration. Following patient-atlas registration, local structural deformations in the brain parenchyma were obtained for every patient by computing statistics from deformation magnitudes obtained from every 5mm annular region, 0 < d < 60 mm, where d is the distance from the tumor infiltrating edge. Multi-class comparison via ANOVA yielded significant differences between deformation magnitudes obtained for Group 3, Group 4, and SHH molecular subgroups, observed up to 60-mm outside the tumor edge. Additionally, Kaplan-Meier survival analysis showed that the local deformation statistics, combined with the current clinical risk-stratification approaches (molecular subgroup information and Chang's classification), could identify significant differences between high-risk and low-risk survival groups, achieving better performance results than using any of these approaches individually. These preliminary findings suggest there exists significant association of our tumor-induced deformation descriptor with overall survival in MB, and that there could be an added value in using the proposed radiomic descriptor along with the current risk classification approaches, towards more reliable risk assessment in pediatric MB.